Medicare Advantage Star Ratings
Expert articles and analysis related to medicare advantage star ratings.
AI Summary — Last 30 Days
In the past 30 days, significant developments in the Medicare Advantage (MA) landscape reflect ongoing tensions surrounding risk adjustment and payment structures. The Trump administration is advocating to keep MA rates flat for the upcoming year while introducing changes to risk adjustment calculations, leading to extensive commentary from insurers, as reflected in the record number of public comments received by CMS on this proposal. Meanwhile, MedPAC estimates indicate a dramatic $76 billion overpayment to MA plans this year relative to traditional Medicare, underscoring the critical financial implications for stakeholders in value-based care, especially as providers navigate these shifting reimbursement models and align their strategies accordingly. Furthermore, insurers like Aetna are grappling with compliance challenges, recently settling a significant case for $117.7 million due to inaccurate diagnosis coding, which could set a precedent for scrutiny in MA risk adjustment practices (Healthcare Dive, Aetna Settlement).
Related Articles
Medicare Advantage ‘dark money’ group attempts to win higher payments for insurance companies
Medicare Advantage ‘dark money’ group attempts to win higher payments for insurance companies Fierce Healthcare
Oversight shrinks Medicare Advantage payment gap to $76B: MedPAC
Oversight shrinks Medicare Advantage payment gap to $76B: MedPAC Modern Healthcare
CMS receives record comments on controversial Medicare Advantage payment proposal
The Trump administration wants to keep MA rates flat next year and change how risk adjustment is calculated. Insurers had a lot to say about this, CMS officials shared Tuesday during an event in D.C.
Humana Introduces New Value-Based Cardiology Care Partnerships for Medicare Advantage Members
Humana Introduces New Value-Based Cardiology Care Partnerships for Medicare Advantage Members Yahoo Finance
CMS threatens Elevance with Medicare Advantage sanctions
CMS threatens Elevance with Medicare Advantage sanctions Healthcare Dive
CMS threatens Elevance with Medicare Advantage sanctions
Federal regulators are planning to suspend enrollment in Elevance's MA plans at the end of March, in a rare and serious threat to the company’s finances.
Considerations for implementing Medicare Advantage encounter data in risk adjustment - MedPAC (.gov)
Considerations for implementing Medicare Advantage encounter data in risk adjustment MedPAC (.gov)
Considerations for implementing Medicare Advantage encounter data in risk adjustment - MedPAC (.gov)
Considerations for implementing Medicare Advantage encounter data in risk adjustment MedPAC (.gov)
Humana’s MaxHealth Deal Tests Medicare Advantage Strategy And Valuation Gap
Humana’s MaxHealth Deal Tests Medicare Advantage Strategy And Valuation Gap Yahoo Finance
The Value Shift – How Medicare Advantage Benefits Are Evolving for 2026
This updated paper builds on Wakely’s prior analysis of Medicare Advantage benefit design, incorporating newly released 2026 enrollment data to provide a clearer picture of how market dynamics are evo...